Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2005-09-20
2005-09-20
Killos, Paul J. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S602000, C514S609000
Reexamination Certificate
active
06946485
ABSTRACT:
Disclosed are methods for inhibiting Ras activity such as cell proliferation associated with vascular injury such as post-angioplasty restenosis and atherosclerosis. Preferred Ras antagonists are S-trans-trans farnesylthiosalicylic acid (FTS) and structurally related compounds (or analogs) thereof.
REFERENCES:
patent: 3910894 (1975-10-01), Wah Wat
patent: 4886916 (1989-12-01), Onishi et al.
patent: 5580955 (1996-12-01), Nur-E-Kamal et al.
patent: 5705528 (1998-01-01), Kloog
patent: 0 315 913 (1989-05-01), None
patent: WO 97/30992 (1997-08-01), None
patent: WO 98/02436 (1998-01-01), None
patent: WO 98/38509 (1998-09-01), None
patent: WO 99/18951 (1999-04-01), None
Marciano, D. et al, Bioorganic and Medicinal Chemistry Letters, vol. 7, No. 13, pp. 1709-1714, 1997.
Reif, et al., Hepatology, 1997, 26(4), part 2: 448A (abstract only).
Ohtsuka, et al., Biochim. Biophys. Acta. 1310:223-232 (1996).
Taneja, et al., J. Clin. Invest. 101:921-926 (1998).
Gana-Weisz, et al., Biochem. Biophys. Res. Commun. 239:900-904 (1997).
Marciano, et al., Bioeng. Med. Chem. Lett. 7:1709-1714 (1997).
Paterson immunological Diseases, 3rd Ed. 1400 Little, Brown and Company, Boston (1978).
Lieder, et al. Science 239:181 (1988).
Varela, et al., Immunol. Today 12:159 (1991).
Cohen, et al., Immunol. Today 12:105 (1991).
Lehmann, et al., Clin Immunol Immunopathol 85:202 (1997).
Aharonson, et al., Biochim. Biophys. Acta 1406:40-50 (1998).
Baldari et al., J. Biol. Chem. 268:2693 (1993).
Siegel, et al., Semin Immunol. 3:325 (1991).
Boguski, et al., Nature 366:643-654 (1993).
Cox, et al., Biochim. Biophys. Acta 1333:F51 (1997).
Marshall, Curr. Opin. Cell Biol. 8:197 (1996).
Scheffzek, et al., Science 277:333 (1997).
Haklai, et al., 37:1306-1314 (1998).
Marciano, et al., J. Med. Chem. 38:1267-72 (1995).
Weisz, et al., Oncogene 18:2579-2588 (1999).
Casey, et al., Proc. Natl. Acad. Sci. USA 86:8323.
Hancock, et al., Cell 57:1167 (1989).
Jansen, et al., Proc. Natl. Acad. Sci. U.S.A 96:14019-14024 (1999).
Martin, et al., Crit Rev Clin Lab Sci 32:121 (1995).
Raine, Ann Neurol 36 (suppl.):S61 (1994).
Hafler, et al., Immunol Today 10:104 (1989).
Lublin, Springer Semin Immunopathol 8:197 (1985).
van der Veen, et al., J Neuroimmunol. 21:183 (1989).
Karussis, et al., J. Neurol Sci 153:239 (1998).
Dalakas, Ann Neurol 37 Suppl 1:S2 (1995).
Lisak, Neurology (1988).
Karussis, et al., J. Immunol. 148:1693 (1992).
Diebler, et al., Prep. Biochem. 2:139 (1972).
Barany, et al., Academic Press, NY 2:1 (1980).
Bernard, et al., J Immunol 114:1537 (1975).
Reif, et al., J. Hepatol. 31:1053-1061 (1999).
Niv, et al., J Biol Chem 274:1606-1613 (1999).
Padula, et al., J Immunol 146:879 (1991).
Kuchroo, et al., J Immunol 148:3776 (1992).
Kaladlubowski, et al., Brain Res 184:439-454 (1980).
Shin, et al., Biochim. Biophys. Res. Commun. 224:5-9 (1996).
Marom, et al., J. Biol. Chem. 270:22263-22270 (1995).
Allen, et al., Org. Synthesis 11:580.
Hann, et al., Lab Invest 59:115-125 (1988).
Cliffer, et al., Muscle Nerve 21:1405-1413 (1998).
Shoenfeld, et al., N Engl J Med 311:1019-29 (1984).
Shoenfeld, et al., Immunol Today 10:123-6 (1989).
Ballow, et al., JAMA 278:2008-17 (1997).
Gharavi, et al., Haemostatis 24:204-7 (1994).
Shoenfeld, Curr. Opin. Rheumatol 1:360-8 (1989).
Brey, et al., Ann NY Acad Sci 823:97-106 (1997).
Mendlovic, et al., Proc Natl Acad Sci USA 85:2260-4 (1988).
Shoenfeld, Isr J Med Sci 30:10-8 (1994).
Krause, et al., Int Arch Allergy Immunol 111:355-61 (1996).
Blank, et al., J Autoimmun, 7:441-55 (1994).
Gharavi, et al. , J. Clin Invest 90:1105-9 (1992).
Garcia, et al., Am J Reprod Immunol 37:118-24 (1997).
Blank, et al., Clin Immunol Immunopathol 54:87-97 (1990).
George, et al., Circulation 97:900-6 (1998).
Brey, et al., Lupus, 6:645-51 (1997).
Cameron, et al., Immunology, 59:187-93 (1986).
Dziarski, J Clin Lab Immunol 16:93-109 (1985).
Bernstein, et al., Clin Exp Immunol 93:418-23 (1993).
Kiberd, et al., J Lab Clin Med 124:496-506 (1994).
Woo, et al., Clin Exp Immunol 100:118-25 (1994).
Warner, et al., Arthritis Rheum 37:289-97 (1994).
Henrickson, et al., Arthritis Rheum 37:587-94 (1994).
Merino, et al., J Autoimmun 8:33-45 (1995).
Hori, et al., Dig Dis Sci 38:2195-202 (1993).
Woessner, Arch Biochem Biophys 93:440-447 (1961).
Muller, et al., Exp Pathol 34:229-36 (1988).
Pinzani, et al., J Clin Invest 90:642-646 (1992).
Casini, et al., Gastroenterology 105:245-253 (1993).
Pinzani, et al., J Clin Invest 84:1786-1793 (1989).
Marra, et al., Gastroenterology 112:1297-1306 (1997).
Carloni, et al., Gastroenterology 1996 110:1127-1136.
Schuppan, et al., Cellular and Molecular Aspects of Cirrhosis, Paris: John Libbey Eurotext, Les Editions INSERM 216:115-34 (1992).
Clement, et al., Molecular and Cell Biology of Liver Fibrogenesis, Dordre: Kluwer Academic Publishers, 85-98 (1992).
Ogawa, et al., Am J Pathol 125:611-619 (1986).
Dashti, et al., Eur Surg Res 21:83-91 (1989).
Chieli, et al., Toxicology 31:41-52 (1984).
Liu, et al., Circulation 79:1374-1387 (1989).
Fuster, et al., N. Engl. J. Med. 236:242-250 (1992).
Libby, et al., Circulation 86 (Suppl.) III47-III52 (1992).
Ross, Nature (Lond.), 362:801-809 (1993).
Hanke, et al., Circulation Res. 67:651-659 (1990).
Shi, et al., Circulation 94:1655-1664 (1996).
Andersen, Circulation 93:1716-1724 (1996).
Ridker, et al., Engl. J. Med. 336:973-979 (1997).
Ridker, et al., Circulation 98:731-733 (1998).
Koeing, Eur. Heart J. Suppl. 1:T19-T26 (1999).
Clowes, et al., Lab Invest. 49:327-334 (1983).
Kaitenbach, et al., Eur. Heart J. 6:276-281 (1985).
Nobuyoshi, et al., J. Am. Coll. Cardiol. 12:616-623 (1988).
RITA Trial Participants (1993) Lancet. 341:573-580.
Califf, et al., J. Am. Coll. Cardiol. 17:2B-13B (1991).
Popma, et al., Circulation 84:1426-1436 (1991).
Franklin, et al., Coronary Artery Dis. 4:232-242 (1993).
Teirstein, et al., N. Eng. J. Med 336:1697-1703 (1997).
Condado, et al., Circulation 96:727-732 (1997).
Katz, et al., JOC 18:1380-1402 (1953).
Allen, et al., Org. Synthesis IV:295.
Okachi, et al., J. Med Chem. 28:1772-1779 (1985).
Carmelin, et al., J. Med Chem 29:743-751 (1994).
Tarbell, et al., Am. Soc. 74:48 (1952).
Tarbell, et al., Org. React. 5:193-228 (1949).
Ding, et al., WO/97/30992, CA 127:278213 (Abstract) (1997).
Rebollo, et al., Blood 94:2971-2980 (1999).
Lange-Carter, et al., Science 265:1458-1461 (1994).
Li, et al., Mol. Cell. Biol. 6:5947-54 (1996).
Chatterjee, et al., Glycobiology 7:703-710 (1997).
Kiaris et al., Atherosclerosis 125:47-51 (1996).
Kloog et al., Exp. Opin. Invest. Drugs 8(12):2121-2140 (1999).
George Jakob
Keren Gad
Kloog Yoel
Killos Paul J.
Lerner David Littenberg Krumholz & Mentlik LLP
Ramot at Tel Aviv University Ltd.
LandOfFree
Treatment of post-angioplasty restenosis and atherosclerosis... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of post-angioplasty restenosis and atherosclerosis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of post-angioplasty restenosis and atherosclerosis... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3446670